Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through strategic partnerships with ...
CordenPharma Colorado is leasing 5505 Central, a newly completed, purpose-built peptide development lab at Flatiron Park in Boulder (US). Photo credit: CordenPharma Photo ...
Harbour BioMed is setting sail as the Solstice begins, riding the waves of biobucks potential that could reach heights up to $1.1 billion. | Harbour BioMed is setting sail as the Solstice begins, ...
Please visit Mainz Biomed’s official website for investors at mainzbiomed.com/investors/ for more information.
Orchestra BioMed has announced that the FDA has granted Breakthrough Device Designation for its atrioventricular interval modulation (AVIM) therapy, aimed at treating over 7.7 million U.S. patients ...
Sino-US biotech Harbour BioMed has announced a license agreement and equity partnership with Solstice Oncology, a clinical ...
SAN DIEGO--(BUSINESS WIRE)--BioMed Realty, a Blackstone portfolio company and leading provider of real estate solutions to the life science and technology industries, announced today that John Lee has ...
BioMed Realty Trust continues to push the life sciences conversion wave in Boston, quietly taking over two prominent development sites. The Blackstone-backed life sciences investor has entered a ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Heightened recognition and ...
Q BioMed's fiscal year concluded on November 30. However, with no definitive timetable yet established for releasing the overdue disclosures, market uncertainty remains elevated. The resolution of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results